Clinical Trial Update: Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia [NA]

View source ↗

Summary

Expanded-access study of HBOC-201 (Hemopure) for life-threatening anemia, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Hemopure (HBOC-201)

Snippet

Sponsor: Englewood Hospital and Medical Center | Conditions: Anemia | NA | Status: ENROLLING_BY_INVITATION